RH

Ross Haghighat

Fluence Corporation Limited | Non-Executive Director
Mr Haghighat has over 30 years of experience in the technology sector as founder or co founder of six companies with a combined shareholder value exceeding $4.5 billion. With over 20 years of operating and strategic roles and a decade in the investment arena, he has helped to create a number of global enterprises in the private and public space in the US, China, Australia and Europe. Mr. Haghighat has been a Non-Executive Director of Fluence Corporation Limited and its predecessor (Emefcy Group Limited) since 2015. He serves as Chairman of Triton Systems Group - a Global Investment and Product Venturing firm. He serves as CEO and Managing Director of BIOS Acquisition Corp (NASDAQ: BIOS), a listed biotech investment company; as non executive director of Chinook Therapeutics (NASDAQ: KDNY) a late clinical stage precision medicine entity; as Chairman of FRX Polymers, a listed Toronto Stock Exchange listed company, and as Chairman of AngleMedical, a PreIPO commercial stage MedTech company

Company and Role

Company
Title
Tenure
Since
FLC
FLC
Fluence Corporation Limited
  • Non-Executive Director
8yrs, 9mthDec 2015

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
FLC
FLC
Fluence Corporation Limited
25/06/24600,000N/A3,500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
FLC
FLC
Fluence Corporation Limited
25/06/24
Issued
1,500,000$0.126$189,000Issue of options
FLC
FLC
Fluence Corporation Limited
06/06/23
Issued
500,000$0.109$54,500Issue of options
FLC
FLC
Fluence Corporation Limited
30/06/22
Issued
500,000$0.156$78,000Issue of options
FLC
FLC
Fluence Corporation Limited
13/07/21
Expiry
1,400,000$0.190$266,000Options expired
FLC
FLC
Fluence Corporation Limited
25/06/21
Issued
1,000,000$0.109$108,900Issue of options